Akdeniz Hall (Hall 2)
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
Following the opening remarks, the session will address regulatory perspectives on GMP Guide Annex 22 and artificial intelligence applications; subsequently, the journey of biotechnological drugs from R&D to production will be comprehensively explored, with expert insights on biosimilars, clinical exemptions, and domestic manufacturing strategies.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Ümit KERVAN, TÜSEB President
>Prof. Dr. F. Ahmet AYAR, TİTCK President
>Şuayip BİNİCİ, TC Deputy Minister of Health
>Prof. Dr. Kemal MEMİŞOĞLU ,TC Minister of Health (If participates)
Regulatory Affairs and Legal Requirements in Pharmaceuticals
Pharmaceutical Regulation in the International Market: Current Approaches and Recent Developments
Moderator: Prof. Dr. Adil MARDINOGLU
>EMA (European Medicines Agency)
>TITCK (Turkish Medicines and Medical Devices Agency)
>Umit DERELI, Secretary General of AIFD
>Savas MALKOC, Secretary General of IEIS
>Sami TURKOGLU, MD, Secretary General of TISD
Novel Biotechnological Molecules and Production Technologies in National and International Markets
Moderatör: Prof.Dr. Ali Demir SEZER
>Dr. Bilgen DÖLEK UÇAROL, Market Access and Health Policy Lead, AMGEN Turkiye
>ROCHE, Speaker
>Dr. Hasan Ersin ZEYTİN, CEO of YERLIKA
>Levent GÜNDEĞER, EEMEA Regional Director, CYTIVA Türkiye
>Ecz. Onur PINARBAŞLI, R&D Director of ILKO
The Pharmaceutical Technologies and API Symposium brings together academia, public institutions, and industry to address the full value chain of pharmaceuticals—from R&D to manufacturing—through a multidisciplinary perspective encompassing biotechnology, artificial intelligence, GMP processes, and clinical research, fostering knowledge exchange and collaboration.
>Prof. Dr. Ali Demir SEZER, Marmara University Faculty of Pharmaceuticals
>Prof. Dr. Orhan AYDIN, TÜBİTAK President
>Doç. Dr. Eren USUL, General Manager of SGK General Health Insurance
> Deputy Minister of Trade & Indutry
TÜBİTAK TEYDEB – ARDEB Grants / Funding Programs
Localization in Biotechnology: Human Resources, Infrastructure, and Ecosystem Model
Moderator: Prof. Dr. Ali Osman KILIC
>Prof. Dr. Cengizhan OZTURK, Bogazici University CT3
>Suha TASPOLAT, CEO of Abdi Ibrahim
>Prof. Dr. Saban TEKIN, General Manager of SBU Technopol
>Cem OZTURK, Head of Sanofi Eurasia Region (or President of Sanofi Eurasia)
>Assoc. Prof. Dr. Ahmet KATI, Scientific Coordinator of OpenLAB Development Academy
Clinical Trials in Biotechnological Drugs and Artificial Intelligence
Moderator: Prof. Dr. Yagiz URESIN, Istanbul University
>Umut MUREN, Clinical Research Unit Director for Sanofi Turkey and Middle East Countries
>Birkan AVER, Primary Care Medical Field Manager, Pfizer Turkey
>Roche, Speaker
Healthcare Financing and Sustainability in the Healthcare Sector
Sector Review Meeting - Closed Session / By Invitation Only
